Bibliography for: "Taro receives approval for generic bactroban ointment"

"Taro receives approval for generic bactroban ointment". Journal of Drugs in Dermatology. FindArticles.com. 02 Jan, 2010. http://findarticles.com/p/articles/mi_m0PDG/is_1_5/ai_n16045497/

Journal of Drugs in Dermatology

View more issues:

Articles in Jan, 2006 issue of Journal of Drugs in Dermatology

• Topical therapies for rosacea
  by Jennie B. Nally
• Ultraviolet B light therapy in the treatment of skin conditions with altered dermal matrix
• Oral therapy for rosacea
  by Hilary E. Baldwin
• Rebound of psoriasis during treatment with efalizumab
  by Nicholas Golda
• New and emerging treatments for acne and photoaging
  by Macrene Alexiades-Armenakas
• FDA approves MimyX cream for the treatment of atopic dermatitis
• Plantar verrucous carcinoma treated with Mohs micrographic surgery: a case report and literature review
  by Ronen Alkalay
• Remicade approved in Europe for plaque psoriasis
• Clobex spray approved by the FDA
• Efficacy and tolerability of Solaraze for 3 months vs 6 months in patients with mild to moderate actinic keratosis
• Lamotrigine-induced erythema multiforme mimicking contact dermatitis
  by Mark Abdelmalek
• A randomized trial of topical 5% 5-fluorouracil in the treatment of actinic keratoses comparing daily with weekly treatment
• Imatinib in dermatofibrosarcoma protuberans
• FDA to review New Drug Application for Oracea
• Improved visibility for the Skin Cancer Foundation
• Oral Zyvox more cost-effective than vancomycin in treatment of skin infections
• FDA approves Humira for psoriatic arthritis
• A letter from the guest editor
  by Mary Lupo
• Exogenous ochronosis
  by M. Huerta Brogeras
• Safety and efficacy study of ICXP007 with compression bandaging for the treatment of non-infected venous leg ulcers
• A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea
• Study to determine the maximum tolerated dose and safety of PEP005 Topical Gel
• Phase IV study to gather more information about the safety of ACZONE Gel, 5% in treating subjects with acne who have G6PD deficiency
• HelixBioPharma to conduct trial in Sweden for condyloma acuminata
• Etanercept for treatment of hidradenitis
• The effect of 0.5% roxithromycin lotion for androgenetic alopecia
• Bullous reaction to topical methchlorethamine in mycosis fungoides
  by Jeff Freed
• Treatment of melasma with Jessner's solution vs trichloroacetic acid
• Rosacea: clinical presentation and pathophysiology
  by Stephanie Diamantis
• Pattern of development of basal versus squamous cell carcinoma
  by Sivan Shemesh
• Treatment of dysplastic nevi with 5% imiquimod cream, a pilot study
  by Stephen W. Dusza
• Adolor to start Phase 2 trial for sterile lidocaine patch
• Efficacy of Elidel cream on erosive oral lichen planus
• Study of ONTAK in cutaneous T-cell lymphoma patients
• Laser and light therapies for acne rosacea
  by Kimberly J. Butterwick
• Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne
  by Macrene Alexiades-Armenakas
• New study demonstrates importance of Elidel in steroid allergic or intolerant patients
• Topical NF-kappa [beta] decoy in the treatment of atopic dermatitis
• Standard high-dose alpha interferon vs intermittent high-dose alpha interferon
• Tinea versicolor clearance with oral isotretinoin therapy
  by Holly Bartell
• Skin Sense Award Gala
• Promising Phase 2 data for oral Rambazole in acne treatment
• Fougera receives tentative approval for generic metronidazole topical gel 0.75%
• Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial
• Ceragenix submits 510 application to FDA for Epiceram, a skin barrier cream for treatment of eczema and other skin disorders
• Classification and characterization of patients treated with efalizumab for plaque psoriasis
• Pegylated interferon-alpha-2a in patients with malignant melanoma stage IIA-IIIB
• Efficacy study of latanoprost and bimatoprost solutions in promoting eyelash growth in patients with alopecia areata
• Antigenics initiates Phase I clinical trial of AG-707 therapeutic vaccine for genital herpes
• Generic Aclovate approved by FDA
• Efficacy and safety of calcipotriol plus betamethasone dipropionate ointment in patients with psoriasis vulgaris
• Dusa acne treatment
• A Phase II, randomized study of ACZONE™ gel, 5% for papulopustular rosacea
• Fighting the good fight
• Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis. A randomized, side-by-side, open-label study
• Taro receives approval for generic bactroban ointment
• Study to determine the safety of two applications of PEP005 topical gel to nodular basal cell carcinoma
• CollaGenex starts Phase II Incyclinide trial for acne
• A study of the use of methotrexate in the treatment of chronic idiopathic urticaria
• Treatment of rosacea with herbal ingredients
  by Jessica Wu
• Intralesional treatment with interleukin-2 in soft tissue melanoma metastases
• Efficacy of calcipotriol plus betamethasone gel versus calcipotriol scalp solution in scalp psoriasis